Vaccines Market Size to reach USD 125.49 Billion


The global vaccines market size is expected to reach USD 125.49 billion in 2028, exhibiting a CAGR of 10.8% during the forecast period. Rising investments for effective medical products and rising demand for effective vaccination during the pandemic are expected to boost the market growth. Fortune Business Insights™ provides this information in its report titled “Vaccines Market, 2021-2028.” As per the report, the market size stood at USD 55.44 billion in 2020 and USD 61.04 billion in 2021.

Vaccines are extremely useful to fight against several infections and reduce fatalities. It protects people from several infections globally. The rising demand for effective immunization is likely to boost the product’s sales. Rising investments in the development of effective medications are expected to boost the product’s demand. The increasing prevalence of infections and disorders is expected to boost the product’s demand. The geriatric population and children are prone to infections, which, in turn, leads to the adoption of effective vaccination. United Nations Children’s Funds (UNICEF) and Pan American Health Organization (PAHO) supply millions of vaccines to countries that require the vaccine. The rising adoption of medical solutions has led to a sudden decline in the prevalence of several diseases. This factor is expected to boost market growth during the upcoming years.

Get Sample PDF Brochure:

North AmericaUnited States, Canada and Mexico
EuropeGermany, UK, France, Italy, Russia and Turkey etc.
Asia-PacificChina, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam etc.
South AmericaBrazil, Argentina, Columbia etc.
Middle East & AfricaSaudi Arabia, UAE, Egypt, Nigeria and South Africa

World Health Organization (WHO) Announces USD 18 Billion COVID-19 Vaccine Initiative to Offer 2 Billion Vaccines

The World Health Organization (WHO) announced over USD 18 billion COVID-19 vaccines in June 2020. Through this initiative, the company shall provide 2 billion vaccines globally. Under the program Coalition for Epidemic Preparedness Innovations (CEPI), Vaccine Alliance and Gavi aim at speeding up their R&D process across all countries. This strategy may enable the companies to establish a distribution and manufacturing infrastructure. This development may boost immunization globally and increase the number of vaccinated individuals.

For More Information :

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245



Please enter your comment!
Please enter your name here

Share post:



More like this

What is Spicyrranny? A Comprehensive Guide to the Culinary Revolution

Introduction Sometimes evolving the world of edible delights, a new...

Read One Punch Man Manga

Is it likely that you truly love energizing movement,...

The Inter Milan vs FC Porto Timeline: A Journey in Football

Welcome football lovers and eager fans to this undeniably...

Amazons GPT44X: Redefining Conversational AI

Envision having a discussion with an artificial intelligence that...